SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants

JAMA. 2021 Mar 2;325(9):821-822. doi: 10.1001/jama.2021.1114.

Authors

John P Moore¹, Paul A Offit²

Affiliations

¹ Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York.
² Division of Infectious Diseases, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

PMID: 33507218
DOI: 10.1001/jama.2021.1114

No abstract available

MeSH terms

Antibodies, Monoclonal / therapeutic use
COVID-19 Vaccines*
COVID-19* / prevention & control
COVID-19* / transmission
COVID-19* / virology
Humans
Mutation*
RNA, Messenger
SARS-CoV-2 / genetics*
Virus Shedding

Substances

Antibodies, Monoclonal
COVID-19 Vaccines
RNA, Messenger